首页> 外文OA文献 >A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

【2h】

A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

机译：IIb期，多中心，开放标签，安全性和有效性研究，用于多剂量骨髓瘤患者自体移植的大剂量无丙二醇盐注射用Melphalan盐酸盐注射液（EVOMELA）的清髓治疗。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hari Parameswaran; Aljitawi Omar S.; Arce-Lara Carlos; Nath Rajneesh; Callander Natalie; Bhat Gajanan; Allen Lee F.; Stockerl-Goldstein Keith;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. A Phase lib, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation [J] . Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第12期

机译：大剂量，无丙二醇盐注射用美法仑盐酸盐注射液（EVOMELA）用于多发性骨髓瘤患者自体移植的清髓治疗的阶段性，多中心，开放标签，安全性和有效性研究
2. Phase II Study of Propylene Glycol-Free Melphalan (Evomela) Combined with Carmustine, Etoposide, and Cytarabine (BEAM) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT) [J] . Cashen Amanda, Gosch Kendall, Fletcher Theresa, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：II期无丙二醇美法仑（Evomela）与卡莫司汀，依托泊苷和阿糖胞苷（BEAM）联合用于自体干细胞移植（ASCT）淋巴瘤患者的清髓条件的II期研究
3. A Phase I/II Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study [J] . Park Sung-Soo, Kim Kihyun, Kim Seok-Jin, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2019,第7期

机译：None
4. Phase 1 Trial of Retroviral-Mediated Transfer of the Human MDR-1 In Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation [C] . Charles Hesdorffer, Janet Ayello, Maureen Ward, Keio International Symposium for Life Sciences and Medicine . 2000

机译：逆转录病毒介导的人MDR-1转移的第1期试验在接受高剂量化疗和自体干细胞移植的患者中
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. A prospective open-label multicenter observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma [O] . Min Kyoung Kim, Kihyun Kim, Chang-Ki Min, 2017

机译：一项前瞻性开放性多中心观察性研究评估硼替佐米-美法仑-泼尼松作为不适合自体干细胞移植的多发性骨髓瘤患者的初始治疗的有效性和安全性
7. Phase IIa, Open-Label, Randomized, Pharmacokinetic Comparative, Cross-Over Study of Melphalan Hcl for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation [O] . Aljitawi O.S., Ganguly S., Abhyankar S., 2012

机译：IIa期，开放标签，随机，药代动力学比较，交叉研究用于自体移植的多发性骨髓瘤患者注射美法仑盐酸盐（不含丙二醇）和注射艾克酮用于清髓性调理。

A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅